Global Short Bowel Syndrome Market Dynamics and Growth Rate 2016-2024 Short Bowel Syndrome Market (Drug Class - GLP-2, G

Short Bowel Syndrome Market (Drug Class - GLP-2,
Growth Hormone, and Glutamine) - Global Industry
Analysis, Size, Share, Volume, Growth, Trends, and
Forecast 2016 – 2024
Global Short Bowel Syndrome Market: Overview
Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack
of functional intestine. SBS can be congenital or an acquired condition which can be observed in
patients in whom nearly half of the small intestine has been removed due to underlying disease
condition. In certain instances, a major part of the large intestine is removed through surgeries that
might result in SBS in the patients. The major causes of SBS in infants include necrotizing enterocolitis,
intestinal atresia, gastroschisis, and malrotation with volvulus, among others. In adults, SBS is
observed in Crohn’s disease, radiation enteritis, and mesenteric ischemia, among others. The
medications prescribed for the treatment of SBS include teduglutide and growth hormones (aid in
intestinal absorption), proton pump inhibitors (used to treat gastric acid secretions), and anti-diarrheal
(to treat the primary symptom of SBS, i.e., diarrhea). As the patients with SBS have lost major part of
the intestine, retaining nutrients in such patients through oral nutrition becomes difficult. Hence
parenteral nutrition is the preferred mode of treatment in these patients.
This 124 -page report gives readers a comprehensive overview of the Short Bowel Syndrome market.
Browse through 07 data tables and 26 figures to unlock the hidden opportunities in this market.
http://www.transparencymarketresearch.com/short-bowel-syndrome-market.html
Global Short Bowel Syndrome Market: Research Methodologies
The research is a combination of primary and secondary research, conducted for understanding and
arriving at trends, used to forecast the expected revenue of drugs employed in the treatment of short
bowel syndrome in the near future. Primary research formed the bulk of our research efforts with
information collected from in-depth interviews and discussions with a number of key industry experts
and opinion leaders. Secondary research involved study of company websites, annual reports, press
releases, investor presentations, analyst presentation and various international and national
databases. The report provides estimated market size in terms of US$ Mn for drug class, and
geography for the period 2014 to 2024, considering the macro and micro environmental factors. The
revenue generated from each drug class was calculated by considering prevalence rate of short bowel
syndrome, the cost of the drugs, reimbursement scenario, drug availability, patent expiries, and
adoption rate of the drugs, across all the geographies.
The market report comprises an elaborated executive summary, which includes market snapshot that
provides information about various segments of the market. It also provides information and data
analysis of the market with respect to market segments based on drug class, and geography. The
market overview section of the report analyzes market dynamics such as drivers, restraints and
opportunities that influences the short bowel syndrome market in the current and future scenario. The
report also provides value chain analysis of the market that describes the sequence of activities
involved, from identification of the market need to their final reach to the end users.